Recurring prostate cancer individual ... - Advanced Prostate...

Advanced Prostate Cancer

17,762 members21,867 posts

Recurring prostate cancer individual seeking Letetium 177 before it spreads more

Willofthewisp profile image
9 Replies

My recent PSMA scan evidenced recurring prostate cancer now in seminal vesticule following proton therapy in 2015. Well respected USA hospital MD said surgery & radiation out due to previous proton radiation & closeness to bladder & rectum. Other than ADT only hope would be to get Letetium 177 treatment to keep cancer from further leaving seminal vesticule.

Any advice would be appreciated

9 Replies
NickJoy profile image
NickJoy

Husband had similar problem but before any radiotherapy to prostate - he had one infusion ac225 and one infusion lu 177 and this reduced the cancer sufficiently for them to have enough of a margin to radiate the prostate. He went to Docrates in Finland.

Tall_Allen profile image
Tall_Allen

Get a second opinion from an expert in high dose rate (HDR) brachytherapy. Only HDR brachytherapy can treat the seminal vesicles.

Willofthewisp profile image
Willofthewisp in reply to Tall_Allen

Per Memorial Sloan Kittering, Vanderbilt, & The West Cancer Clinic, I am not a candidate for HDR brachytherapy as my seminal vesicles butt right up against my rectum and bladder. It would be like dropping a stone in the water to hit the target, but the ongoing surrounding waves would wreck havoc on my bladder & rectum in a way that would not be desirable. Thank u very much for your response though.

Paver1 profile image
Paver1 in reply to Tall_Allen

I had hole gland proton radiation, does that not treat the seminal vesicles?

Tall_Allen profile image
Tall_Allen in reply to Paver1

For primary treatment, seminal vesicles are usually treated with radiation only in high risk patients. The OP was asking about salvage treatment, not primary treatment, If HDR brachy couldn't be used for salvage, protons wouldn't be a viable option either.

tango65 profile image
tango65

Since the cancer is hormone sensitive and apparently is not metastatic, I would look for Lu 177 PSMA therapy abroad, probable in Vienna or India.

j-o-h-n profile image
j-o-h-n

Greetings Will,

Would you please be kind enough to tell us your bio. Age? Location? When Treatment(s)? Treatment center(s)? Scores Psa/Gleason? Medications? Doctor's name(s)?

ALL INFO IS VOLUNTARY, but it helps us help you and helps us too. When you respond, you might want to copy and paste it in your home page for your use and for other members’ reference.

Note: Answers are for your benefit, not mine.

THANK YOU AND KEEP POSTING!!!

Good Luck, Good Health and Good Humor.

j-o-h-n Thursday 06/16/2022 11:47 PM DST

Abhishek_Roy profile image
Abhishek_Roy

I think their is a shortage of Lu177 although I am not sure. You must have to take a second opinion. Suggesting Dr Sen ishitasen from FMRI India. Talk to her. She is available at dr.ishitasen@nuclearmedicinetherapy.in

ishitasen profile image
ishitasen

Lu177 PSMA has been used in hormone-sensitive prostate cancer with small volume metastatic disease (less than 10 sites of metastases) with favorable results. Although not a standard of care intervention, recent data shows that lu177 allowed patients to defer ADT and maintain a good quality of life. Attaching the link of a recently published article

doi.org/10.3389/fnume.2022....

Points to be considered against Lu177 PSMA therapy are the salivary gland toxicity and the risk of bone marrow suppression

You may also like...